Print

Purpose

The purpose of this study is to understand if it is safe and useful to perform SGB (Stellate Ganglion Block) in patients who have severe lung injury Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 infection.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 80 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subjects age 18 to 80 - Subjects with PCR documented diagnosis of COVID-19 ARDS requiring critical care and transfer to intensive care unit - Bilateral opacities consistent with pulmonary edema must be present and may be detected on CT or chest radiograph

Exclusion Criteria

  • Subjects with pre-existing cardiac failure - Hemodynamic Instability - Subject on Extracorporeal membrane oxygenation (ECMO) - Anatomical inability to do a stellate block

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Stellate Ganglion Block (SGB) 		Clinical Stellate ganglion block
  • Procedure: Stellate Ganglion Block
    The procedure will be done at the bedside in the ICU without interfering with ongoing treatment.

Recruiting Locations

More Details

NCT ID
NCT04402840
Status
Completed
Sponsor
West Virginia University

Detailed Description

Primary Aim: • To determine safety of stellate ganglion block (SGB) in ARDS Secondary Aim: - To determine efficacy of SGB in slowing the progression of ARDS

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.